GENFIT - ALGFT - FR0004163111

Beleggen in aandelen beurzen Frankfurt DAX, Londen FTSE 100, Parijs CAC40
Stofke
Premiummember
Premiummember
Berichten: 593
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 312
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 31 Jan 2019 21:20

Genfit And Elafibranor In NASH Fibrosis: The FDA Guidelines For Conditional Approval

https://seekingalpha.com/amp/article/42 ... ssion=true




Word gratis lid op Beursig.com

Discussieer met duizenden andere beleggers en
profiteer van minder advertenties, abonneren op
favoriete onderwerpen en toegang tot de chatbox.

Registreer u binnen enkele tellen



powered by Surfing Waves

Stofke
Premiummember
Premiummember
Berichten: 593
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 312
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 18 Feb 2019 11:10

ZGlobal NASH Congress
February 25-26, 2019
London

http://www.global-engage.com/event/nash/

Stofke
Premiummember
Premiummember
Berichten: 593
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 312
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 24 Feb 2019 17:46

Most NASH biotechs are years behind, but there is a good chance for Genfit (OTCPK:GNFTF) to capitalize where Intercept failed.

https://seekingalpha.com/amp/article/42 ... ssion=true

Stofke
Premiummember
Premiummember
Berichten: 593
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 312
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 26 Feb 2019 18:51

Nonalcoholic Steatohepatitis Therapeutics Market will Cross US$20.27 bn by 2025

https://honestversion.com/nonalcoholic- ... n-by-2025/

Stofke
Premiummember
Premiummember
Berichten: 593
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 312
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 27 Feb 2019 22:06

Genfit kondigt de indiening aan van een registratiedocument voor de geplande beursintroductie in de Verenigde Staten

https://www.genfit.com/press-release/ge ... ed-states/

Stofke
Premiummember
Premiummember
Berichten: 593
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 312
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 03 Mar 2019 10:26

Genfit May Become Very Interesting By The End Of 2019

https://seekingalpha.com/amp/article/42 ... ssion=true

Stofke
Premiummember
Premiummember
Berichten: 593
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 312
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 06 Mar 2019 16:37

Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis

http://www.clinsci.org/content/133/3/531

Stofke
Premiummember
Premiummember
Berichten: 593
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 312
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 11 Mar 2019 08:24

GENFIT announces FDA Protocol Clearance for Phase 2 Clinical Trial of Elafibranor in Pediatric NASH

https://www.genfit.com/press-release/ge ... tric-nash/

BDM Holding
Forum newbie
Forum newbie
Berichten: 4
Lid geworden op: 24 Jan 2019 11:09
waarderingen: 0
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor BDM Holding » 14 Mar 2019 20:06

GENFIT announces Launch of Proposed Global Offering and Nasdaq listing

https://www.genfit.com/press-release/ge ... q-listing/

Stofke
Premiummember
Premiummember
Berichten: 593
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 312
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 14 Mar 2019 22:05

#PressRelease GENFIT announces Launch of Proposed Global Offering and Nasdaq listing

https://www.genfit.com/press-release/ge ... q-listing/